Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

As gastroenterology research progresses, it is critical to comprehend the connection between stomach cancer and gastric ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Learn more about whether ACADIA Pharmaceuticals Inc. or Legend Biotech Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Viking Therapeutics VKTX is set to report fourth-quarter and full-year 2024 earnings on Feb. 5, after market close. Since the ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

"We talk about the S-curve for technology and in the past we've said it can be 10 or 20 years before you reach the top. I think what's going to be really different about AI is that time frame is going ...